🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer, Stage 0

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery NCT06297265NA1 site📍 Los Angeles University of Southern California · Tests: Lymphedema Management, Questionnaire Administration, Adjuvant breast radiation therapy CONFIRM: Magnetic Resonance Guided Radiation Therapy NCT04368702NA2 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Viewray MRIdian® Linac A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery NCT04169542n/a4 sites📍 Conroe📍 Houston📍 League City M.D. Anderson Cancer Center · Tests: Questionnaire Administration A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors NCT06700070EARLY Phase 11 site📍 Shreveport Pure Biologics S.A. · Tests: PBA-0111 Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer NCT03936478Phase 21 site📍 Madison University of Wisconsin, Madison · Tests: MRIdian Radiation Treatment Unit Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer NCT02918474NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Decision Aid, Questionnaire Administration Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab NCT05760612Phase 31 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Trastuzumab and neratinib, Trastuzumab and Pertuzumab Perioperative Mindfulness Proposal NCT04049214NA1 site📍 Newport Beach Hoag Memorial Hospital Presbyterian · Tests: Meditation A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer NCT07205822Phase 340 sites📍 Largo📍 Fort Wayne📍 Omaha AstraZeneca · Tests: Dato-DXd PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808EARLY Phase 11 site📍 Groningen Var2 Pharmaceuticals · Tests: 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) NCT04985032n/a2 sites📍 Stuart📍 Tampa RPCR, Inc. · Tests: stereotactic body radiation therapy ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy NCT06185205Phase 21 site📍 Richmond Virginia Commonwealth University · Tests: Accelerated partial breast irradiation Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer NCT04959474NA1 site📍 Philadelphia Thomas Jefferson University · Tests: Best Practice, Stereotactic Body Radiation Therapy, Resection, Sentinel Lymph Node Biopsy, Dietary Intervention Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial NCT06184750Phase 211 sites📍 Tucson📍 Chicago📍 Chicago National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Mammography, Questionnaire Administration, Tamoxifen Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ NCT06218303Phase 11 site📍 Pittsburgh Finn, Olivera, PhD · Tests: MUC1 Peptide Vaccine, Hiltonol®, Aromatase Inhibitor, Selective estrogen receptor modulator (SERM) Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction NCT05490433NA17 sites📍 Changwon📍 Daegu📍 Daegu Yonsei University · Tests: Robot-assisted Nipple-Sparing Mastectomy (RNSM), Conventional nipple sparing mastectomy(CNSM) Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery NCT07762885Phase 31 site📍 Shanghai Fudan University · Tests: Adjuvant Radiotherapy, tamoxifen Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer NCT06984250n/a2 sites📍 Taipei📍 Taipei National Taiwan University Hospital · Tests: Hypofractionated Radiation Therapy Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) NCT06902311Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Breast Radiotherapy Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer NCT06380751Phase 3306 sites📍 Gilbert📍 Fountain Valley📍 Glendale AstraZeneca · Tests: Saruparib (AZD5305), Camizestrant, Abemaciclib, Ribociclib, Palbociclib Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer NCT04603209n/a1 site📍 Santa Monica Saint John's Cancer Institute · Tests: Intraoperative Radiation Therapy (IORT) Identifying and Caring for Individuals With Inherited Cancer Syndrome NCT04494945NA2 sites📍 Portland📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Genetic Counseling, Genetic Testing, Survey Administration Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy NCT06401889n/a1 site📍 Jacksonville Mayo Clinic · Tests: Non-Interventional Study Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy NCT07711847NA1 site📍 New York HeroSupport SA · Tests: VENUS SHELL™ immobilization device EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer NCT06115486NA1 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: Control Arm ACSM Guidelines, Experimental Arm 6-12-25 repetitions per set Trial of Trastuzumab Deruxtecan in Previously Treated HER2 NCT06750484Phase 23 sites📍 New Haven📍 Atlanta📍 Rochester Yale University · Tests: Trastuzumab Deruxtecan A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial NCT07443943Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Starch, Potato The PREDICT Registry: NCT03448926n/a30 sites📍 Scottsdale📍 La Jolla📍 San Mateo PreludeDx · Tests: Treatment recommendation surveys, 7-gene biosignature A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer NCT06827236Phase 1, Phase 281 sites📍 Beverly Hills📍 Newport Beach📍 Port Saint Lucie BioNTech SE · Tests: BNT323, BNT327
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy